novo nordisk cagrilintide Wegovy Maker Files for FDA Approval of Obesity Drug CagriSema Novo Nordisk's next-gen obesity drug
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28




























